Silk Road Medical to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

SUNNYVALE, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. SILK, a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Morgan Stanley 19th Annual Global Healthcare Conference.

Silk Road Medical's management is scheduled to present on Tuesday, September 14, 2021 at 2:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company's website at: https://investors.silkroadmed.com/.

About Silk Road Medical
Silk Road Medical, Inc. SILK, is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com